Alden Optical Laboratories, Inc.

Alden Optical Laboratories, Inc. is a foreign-owned, for-profit manufacturer of optical goods registered with the federal government since April 2010. The company specializes in the design and manufacture of precision optical devices, including specialized contact lenses and vision care products. Alden Optical Laboratories serves the federal government primarily through the Defense Health Agency, providing medical optical supplies that support military healthcare operations and beneficiary populations.

Alden Optical Laboratories has demonstrated expertise in delivering specialized optical products through direct contract awards from the Defense Health Agency. Most recently, the company received a firm fixed-price purchase order valued at $42,788 on July 25, 2025, for Zenlens scleral lenses to be delivered by September 30, 2025, with performance in San Antonio, Texas. Scleral lenses are therapeutic contact lenses designed for patients with irregular corneas or other ocular conditions, and this award demonstrates the company's capability to fulfill time-sensitive medical supply requirements for military treatment facilities. The contract was awarded without any set-aside designation, reflecting a straightforward commercial procurement for specialized medical products. This purchase order represents the company's ability to provide precision optical devices that meet the specific clinical needs of the Defense Health Agency's healthcare delivery mission.

Alden Optical Laboratories holds two active Blanket Purchase Agreements with the Defense Health Agency that establish ongoing vendor relationships for optical products and services. The first BPA, awarded on April 1, 2024, with a ceiling value of $187,296 and performance through March 31, 2027, supports customized scleral contact lenses for the Womack Army Medical Center, specifically serving the Primary Care Residency Program by providing Active Duty residents with hands-on experience in eye examinations and contact lens fittings for Soldiers and authorized DoD beneficiaries. This was awarded as a single-award, sole source contract with no set-aside designation. The second BPA, established on October 1, 2021, with a potential value of $81,244.83 extending through September 30, 2026, provides a broader range of eyeglasses, vision care products, and vision examination services to eligible military service members, veterans, and their families at locations worldwide. This contract also represents a single-award arrangement with no set-aside provisions. Together, these BPAs demonstrate the Defense Health Agency's confidence in Alden Optical Laboratories' ability to serve as a primary supplier for optical products and vision care across multiple military healthcare locations and populations.